Headlines

Candel Therapeutics' CAN-2409 Enhances NSCLC Survival In Phase 2 Trial; Stock Surges

posted: Thu, 05/23/2024 - 22:53 EDT

by: Nasdaq News

#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks

SAB Biotherapeutics Gets FDA Clearance To Advance Phase 1 Trial Of SAB-142 In Type-1 Diabetes

posted: Tue, 05/21/2024 - 08:07 EDT

by: Nasdaq News

#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks

Ionis Reports Positive Topline Data From The HALOS Phase 1/2a Study In Angelman Syndrome

posted: Thu, 05/16/2024 - 07:59 EDT

by: Nasdaq News

#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks

Actinium : Iomab-B Phase 3 Trial Results Show Significant Survival Benefit In High-Risk AML Patients

posted: Tue, 05/14/2024 - 22:38 EDT

by: Nasdaq News

#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks

Moderna's MRNA-1283 COVID-19 Vaccine Design Meets Primary Endpoints In Phase 3 Clinical Trial

posted: Tue, 03/26/2024 - 11:24 EDT

by: Nasdaq News

#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks

Axsome Therapeutics' Phase 3 SYMPHONY Study In Narcolepsy Meets Primary Goal

posted: Mon, 03/25/2024 - 07:10 EDT

by: Nasdaq News

#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks

Crinetics Pharma Stock Rises On Announcement Of Positive Data From Phase 3 Studies Of Paltusotine

posted: Tue, 03/19/2024 - 12:49 EDT

by: Nasdaq News

#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks

Innovent : Phase 2 Trial Of IBI302 In Neovascular Age-related Macular Degeneration Meets Main Goal

posted: Mon, 03/18/2024 - 21:51 EDT

by: Nasdaq News

#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks

Sanofi's Phase 2b Results Support Amlitelimab's Potential In Atopic Dermatitis

posted: Mon, 03/11/2024 - 02:37 EDT

by: Nasdaq News

#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks

Larimar Therapeutics Reports Positive Data From Nomlabofusp Phase 2 Study In FA Patients

posted: Mon, 02/12/2024 - 07:32 EST

by: Nasdaq News

#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks

Kura Gains 17% Over Positive Preliminary Clinical Data From Phase 1 Trial Of Ziftomenib

posted: Tue, 01/30/2024 - 11:25 EST

by: Nasdaq News

#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks

Merck's Keytruda Reduces Risk Of Death By 38% In Adjuvant RCC Therapy In Phase 3 Trial

posted: Sun, 01/28/2024 - 19:53 EST

by: Nasdaq News

#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks

Putin, Sisi mark new phase of Egypt's Russian-built nuclear plant

posted: Tue, 01/23/2024 - 10:03 EST

by: Nasdaq News

#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks

Innovent Biologics : Phase 3 Trial Of Mazdutide In Obesity Meets Primary And Secondary Endpoints

posted: Mon, 01/08/2024 - 22:49 EST

by: Nasdaq News

#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks

Applied Therapeutics Announces Mixed Results From Phase 3 Trial Of AT-001 In Diabetic Cardiomyopathy

posted: Thu, 01/04/2024 - 20:52 EST

by: Nasdaq News

#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks